Back

Myocardial microvascular dysfunction in asymptomatic patients with hereditary dyslipidemia

27 August 2023 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Ischaemia without obstructive disease Coronary Circulation, Flow, and Flow Reserve ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Tigist Wodaje

Karolinska University Hospital, Stockholm (Sweden)

6 More presentations in this session

Presentation thumbnail
Long-term outcomes of patients with ischemia and no obstructive coronary artery disease (INOCA) - a systematic review and meta-analysis
Doctor N. Odanovic (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Coronary vasomotor disorders in ANOCA patients: insights from the CADOSA registry.
Ms S. La (Adelaide, AU)
Abstract Slides Video
Presentation thumbnail
Resting and stress coronary flow velocity for identification of different endotypes and risk classes in ANOCA patients beyond coronary flow velocity reserve
Doctor N. Gaibazzi (Parma, IT)
Abstract Slides Video
Presentation thumbnail
Impact of chronic kidney disease on the association of vascular endothelial growth factor D with cardiovascular mortality in patients with suspected or known coronary artery disease: the ANOX study
Professor K. Hasegawa (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
Improvement of symptoms and quality of life in patients with coronary vasomotion disorders by endotype-based drug therapy
Professor P. Ong (Stuttgart, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Ischaemia without obstructive disease

The Event

Event poster

ESC Congress 2023

27 August 2023 08:15 CET
You may be interested in
thumbnail
Congress Session
Atypical coronary syndromes
thumbnail
Congress Presentation
Invasive assessment of coronary microvascular dysfunction with MACEs: a meta-analysis
thumbnail
Congress Presentation
Coronary microvascular dysfunction endotypes and clinical outcomes in patients with ischemia and no obstructive coronary arteries: A meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources